Imitrex (sumatriptan) was the first migraine medication approved to abort an attack. Discover its side effects, benefits, and ...

Sumatriptan (as succinate) 4mg/0.5mL, 6mg/0.5mL; for SC inj. Imitrex Injection is supplied as a clear, colorless to pale yellow, sterile, nonpyrogenic solution as either prefilled syringe and/or ...

Tosymra Nasal Spray 10 mg is a Proprietary Acute Migraine Treatment Approved Under the 505(b)2 Pathway Based on Bioequivalence to Imitrex (sumatriptan) Injection 4 mg GlaxoSmithKline Recently Notified ...

Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...

Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...

Tosymra (sumatriptan) is a prescription drug used to treat migraine. The drug comes as a nasal spray. You usually use a single dose, which may be repeated two more times in a 24-hour period if needed.

MUMBAI, Feb 17 (Reuters) - Drug firm Wockhardt Ltd on Tuesday said it will be launching Sumatriptan injections in the U.S. following following final approval from the U.S. Food & Drug Administration.

Imitrex is available as a generic drug. The maximum single recommended adult dose of Imitrex Injection for the acute treatment of migraine or cluster headache is 6 mg injected subcutaneously. For the ...

Imitrex (sumatriptan) is a prescription drug that’s used to treat migraine with or without an aura. It’s not known whether Imitrex may be safe to use while pregnant or breastfeeding. If you can become ...

Sumatriptan (as succinate) 25mg, 50mg, 100mg. 25mg – white, triangular-shaped, film-coated tablets debossed with “I” on one side and “25” on the other in blister packs of 9 tablets. 50mg – white, ...

May 7 (Reuters) - Spectrum Pharmaceuticals Inc said it sold a majority of its stake in profits from a generic version of migraine injection sumatriptan to Par Pharmaceutical Inc for $20 million. This ...